New $1 HIV/syphilis/hepatitis B test bundle targets high-volume African markets

A new $1 bundled test for HIV, syphilis, and hepatitis B is being rolled out, with Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique, and South Africa identified as high-volume markets for antenatal screening. The initiative aims to improve maternal health outcomes by enabling low-cost, integrated testing in resource-limited settings. The claim is based on company analysis; actual market uptake and impact remain to be seen.